Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02452775
Title Autologous OC-L Vaccine and Ovarian Cancer
Recruitment Terminated
Gender female
Phase Phase I
Variant Requirements No
Sponsors Abramson Cancer Center of the University of Pennsylvania
Indications

peritoneum cancer

fallopian tube cancer

ovarian cancer

Therapies

OC-L

Age Groups: adult
Covered Countries USA


No variant requirements are available.